Aptose Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.98-2.88-3.89-6.00
Price/Sales ratio
369.964.8736.4228.27
Earnings per Share (EPS)
$-2.14$-0.73$-0.54$-0.35

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-399.82-0.19-0.08-0.28-0.14-0.73-0.43-0.12-0.08-0.33-0.75-0.73
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
0.180.140.160.320.300.200.200.100.09-5.911.270.30
Price/Cash Flow ratio
-0.46-0.21-0.09-0.32-0.18-0.87-0.70-0.18-0.11-0.38-2.03-0.87
Price/Free Cash Flow ratio
-0.44-0.21-0.09-0.32-0.18-0.87-0.70-0.18-0.11-0.38-2.88-0.87
Price/Earnings Growth ratio
4.00-0.00-0.000.00-0.000.01-0.01-0.010.00-0.02-0.030.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A-0.29%0.25%-0.83%0.15%2.20%0.95%0.14%1.84%N/AN/A2.20%
Return on Assets
-0.04%-68.83%-160.43%-97.44%-171.12%-25.57%-43.32%-79.08%-80.45%-394.23%-125.16%-171.12%
Return On Equity
-0.04%-77.41%-189.29%-114.30%-205.01%-27.35%-46.00%-87.91%-108.77%1765.14%-124.42%-205.01%
Return on Capital Employed
-0.04%-85.21%-189.69%-115.91%-206.71%-28.29%-46.69%-88.02%-109.93%2296.31%-83.10%-206.71%
Liquidity Ratios
Current Ratio
N/A8.836.396.695.9117.8318.36N/AN/AN/A4.0317.83
Quick Ratio
13.488.836.396.695.9117.8318.369.994.030.773.8217.83
Cash ratio
6.174.886.026.025.4814.4117.234.783.000.603.0014.41
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A1.98K3.352.41K5.74K1.14K1.22K1.00K4.55K4.65KN/A1.14K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.03N/AN/AN/AN/A0.000.00N/AN/AN/A0.260.00
Debt Equity Ratio
0.03N/AN/AN/AN/A0.000.00N/AN/AN/A0.350.00
Long-term Debt to Capitalization
0.01N/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Total Debt to Capitalization
0.03N/AN/AN/AN/A0.000.00N/AN/AN/A0.030.00
Interest Coverage Ratio
N/A-643.96-282.81N/AN/AN/AN/AN/AN/AN/A-83.20N/A
Cash Flow to Debt Ratio
-11.83N/AN/AN/AN/A-41.37-62.87N/AN/AN/A-18.16-41.37
Company Equity Multiplier
1.071.121.171.171.191.061.061.111.35-4.471.351.19
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.031.021.001.001.011.001.001.001.001.000.701.00
Cash Flow Coverage Ratio
-11.83N/AN/AN/AN/A-41.37-62.87N/AN/AN/A-18.16-41.37
Short Term Coverage Ratio
-28.08N/AN/AN/AN/A-41.37-62.87N/AN/AN/A-78.64-41.37
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A